Nirmatrelvir/ritonavir Use With Tacrolimus in Lung Transplant Recipients: A Single-center Case Series
Katherine Dewey(University of California, San Francisco), Rebecca Florez(University of California, San Francisco), Steven R. Hays(University of California, San Francisco), David N. Quan(University of California, San Francisco), Ripal Jariwala(University of California, San Francisco), Jonathan P. Singer(University of California, San Francisco), Bethanne Carpenter(University of California, San Francisco), Karen Breen(Guy's and St Thomas' NHS Foundation Trust), Leslie Seijo(University of California, San Francisco), Jose Lazo(University of California, San Francisco), Bo Yen(University of California, San Francisco), Rupal Shah(California University of Pennsylvania)
Cited by 22
Related Papers
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686
Whole-Body MRI Versus PET in Assessment of Multiple Myeloma Disease Activity
|American Journal of Roentgenology|2009|184
The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia
|British Journal of Haematology|2011|136
HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies
|Seminars in Thrombosis and Hemostasis|2017|125
Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom
|Thrombosis Research|2020|122